Overview

Lung Health Study II

Status:
Completed
Trial end date:
1999-05-01
Target enrollment:
Participant gender:
Summary
To determine if participants with chronic obstructive pulmonary disease, who were assigned to inhaled corticosteroids had a lower rate of decline in lung function and lower incidence of respiratory morbidity compared to participants assigned to placebo.
Phase:
Phase 3
Details
Lead Sponsor:
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide